Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Karin Eastham


  • Director at Nektar Therapeutics (NKTR), 2019-09-27
  • Director at Personalis Inc. (PSNL), 2019-09-16
  • Director at Veracyte Inc. (VCYT), 2019-06-13
  • Director at Geron Corp (GERN), 2019-06-07
  • Director at Illumina Inc (ILMN), 2019-05-29
  • Director at Trius Therapeutics Inc (TSRX), 2013-09-13
  • Director at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10
  • Director at Genoptix Inc (GXDX), 2011-03-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ILMN $296.78 100 Director 10,838 2019-01-02 Filing
ILMN $295.93 117 Director 10,938 2019-01-02 Filing
ILMN $294.73 232 Director 11,055 2019-01-02 Filing
ILMN $293.59 350 Director 11,287 2019-01-02 Filing
ILMN $292.27 134 Director 11,637 2019-01-02 Filing